Serologic evidence of human metapneumovirus circulation in Uruguay.
First identified in 2001, the human metapneumovirus (hMPV), is a respiratory tract pathogen that affects young children, elderly, and immunocompromised patients. The present work represents the first serologic study carried out in Uruguay. It was performed with the purpose of obtaining serological evidence of hMPV circulation in Uruguay and to contribute to the few serologic reports described until now. Sixty nine serum samples collected between 1998 and 2001 by vein puncture from patients without respiratory symptoms or underlying pathology aged 6 days to 60 years were examined using an indirect immunofluorescence assay (IFA). The global seropositivity rate of the samples was 80% (55/69). Rates of 60% (15/25) and 91% (40/44) were observed for the pediatric and adult cohorts, respectively. Results obtained from a longitudinal analysis of 6 children aged 6 days to 18 months are discussed. These results are a clear evidence of hMPV circulation in Uruguay, at least since 1998, and reinforce the previous data on worldwide circulation of this virus.
Mirazo
Santiago
S
Sección Virología, Facultad de Ciencias, Universidad de la República, Iguá 4225, CP 11400, Montevideo, Uruguay.
Ruchansky
Dora
D
Blanc
Andrea
A
Arbiza
Juan
J
D000293:Adolescent; D000328:Adult; D000914:Antibodies, Viral / Q000097:blood*; D019084:Fluorescent Antibody Technique, Indirect; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008137:Longitudinal Studies; D029121:Metapneumovirus / Q000235:genetics / Q000276:immunology; D008875:Middle Aged; D018184:Paramyxoviridae Infections / Q000453:epidemiology* / Q000821:virology; D015995:Prevalence; D020133:Reverse Transcriptase Polymerase Chain Reaction; D016036:Seroepidemiologic Studies; D014583:Uruguay / Q000453:epidemiology
D000914:Antibodies, Viral